Filing Details

Accession Number:
0001093557-17-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-18 19:37:15
Reporting Period:
2017-01-13
Filing Date:
2017-01-18
Accepted Time:
2017-01-18 19:37:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343856 A Jorge Valdes 6340 Sequence Drive
San Diego CA 92121
Cto No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-13 8,927 $9.80 81,261 No 4 M Direct
Common Stock Disposition 2017-01-13 8,927 $80.00 72,334 No 4 S Direct
Common Stock Acquisiton 2017-01-13 10,000 $7.63 82,334 No 4 M Direct
Common Stock Disposition 2017-01-13 10,000 $80.00 72,334 No 4 S Direct
Common Stock Acquisiton 2017-01-13 7,173 $9.80 79,507 No 4 M Direct
Common Stock Disposition 2017-01-13 7,173 $80.00 72,334 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2017-01-13 10,000 $80.00 10,000 $7.63
Common Stock Incentive Stock Option (right to buy) Disposition 2017-01-13 8,927 $80.00 8,927 $9.80
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-01-13 7,173 $80.00 7,173 $9.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-05-19 2018-05-19 No 4 M Direct
0 2011-03-12 2020-03-12 No 4 M Direct
20,900 2011-03-12 2020-03-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,499 Indirect by Trust
Footnotes
  1. On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
  3. Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.